Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew N. Schiff files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Filip Janku - $1.38M in GLUE purchases and sales in the last 12 months
- Braden Michael Leonard - $1.36M in ACRS purchases and sales in the last 12 months
- Markus Warmuth - $951K in GLUE purchases and sales in the last 12 months
- Edmund Dunn - $483K in GLUE purchases and sales in the last 12 months
- Sharon Townson - $424K in GLUE purchases and sales in the last 12 months
- Anthony M. Manning - $411K in GLUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew N. Schiff?
Andrew N. Schiff is a corporate insider of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew N. Schiff last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 4 filings going back to 2025.
